vs
康美（CNMD）与Streamex Corp.（STEX）财务数据对比。点击上方公司名可切换其他公司
过去两年Streamex Corp.的营收复合增速更高（NaN% vs NaN%）
康美公司是一家上市的美国医疗设备制造商，主营骨科、腹腔镜、普通外科相关医疗器械以及各类患者护理产品，总部现位于佛罗里达州拉戈，2022年7月前设于纽约州尤蒂卡。该品牌秉持以人为本的文化，以助力医疗合作方及其服务的患者为核心使命，在美国和墨西哥都设有生产基地。
CNMD vs STEX — 直观对比
营收规模更大
CNMD
是对方的-37319.7倍
$-10.0K
两年增速更快
STEX
近两年复合增速
9.3%
损益表 — Q4 2025 vs Q3 2025
| 指标 | | |
|---|---|---|
| 营收 | $373.2M | $-10.0K |
| 净利润 | — | $-15.6M |
| 毛利率 | 58.5% | — |
| 营业利润率 | 9.8% | 61130.0% |
| 净利率 | — | 155840.0% |
| 营收同比 | 7.9% | — |
| 净利润同比 | — | -714.2% |
| 每股收益（稀释后） | $0.54 | $-0.47 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CNMDSTEX
| Q4 25 | $373.2M | — | ||
| Q3 25 | $337.9M | $-10.0K | ||
| Q2 25 | $342.3M | $13.0K | ||
| Q1 25 | $321.3M | — | ||
| Q4 24 | $345.9M | $13.0K | ||
| Q3 24 | $316.7M | $0 | ||
| Q2 24 | $332.1M | $13.0K | ||
| Q1 24 | $312.3M | $14.0K |
净利润CNMDSTEX
| Q4 25 | — | — | ||
| Q3 25 | $2.9M | $-15.6M | ||
| Q2 25 | $21.4M | $-20.4M | ||
| Q1 25 | $6.0M | — | ||
| Q4 24 | — | $-1.1M | ||
| Q3 24 | $49.0M | $-1.9M | ||
| Q2 24 | $30.0M | $-3.9M | ||
| Q1 24 | $19.7M | $-3.4M |
毛利率CNMDSTEX
| Q4 25 | 58.5% | — | ||
| Q3 25 | 49.2% | — | ||
| Q2 25 | 55.0% | — | ||
| Q1 25 | 55.3% | — | ||
| Q4 24 | 57.3% | — | ||
| Q3 24 | 56.5% | — | ||
| Q2 24 | 55.3% | — | ||
| Q1 24 | 55.1% | — |
营业利润率CNMDSTEX
| Q4 25 | 9.8% | — | ||
| Q3 25 | 3.5% | 61130.0% | ||
| Q2 25 | 11.1% | -156653.8% | ||
| Q1 25 | 5.0% | — | ||
| Q4 24 | 15.2% | -9100.0% | ||
| Q3 24 | 20.7% | — | ||
| Q2 24 | 14.2% | -40707.7% | ||
| Q1 24 | 11.2% | -24550.0% |
净利率CNMDSTEX
| Q4 25 | — | — | ||
| Q3 25 | 0.8% | 155840.0% | ||
| Q2 25 | 6.3% | -156707.7% | ||
| Q1 25 | 1.9% | — | ||
| Q4 24 | — | -8453.8% | ||
| Q3 24 | 15.5% | — | ||
| Q2 24 | 9.0% | -30115.4% | ||
| Q1 24 | 6.3% | -24300.0% |
每股收益（稀释后）CNMDSTEX
| Q4 25 | $0.54 | — | ||
| Q3 25 | $0.09 | $-0.47 | ||
| Q2 25 | $0.69 | $-0.74 | ||
| Q1 25 | $0.19 | — | ||
| Q4 24 | $1.09 | $0.03 | ||
| Q3 24 | $1.57 | $-0.12 | ||
| Q2 24 | $0.96 | $-0.30 | ||
| Q1 24 | $0.63 | $-0.36 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | — |
| 总债务越低越好 | $834.2M | — |
| 股东权益账面价值 | $1.0B | $-7.0M |
| 总资产 | $2.3B | $130.5M |
| 负债/权益比越低杠杆越低 | 0.81× | — |
8季度趋势，按日历期对齐
总债务CNMDSTEX
| Q4 25 | $834.2M | — | ||
| Q3 25 | $853.0M | — | ||
| Q2 25 | $881.1M | — | ||
| Q1 25 | $891.4M | — | ||
| Q4 24 | $905.1M | — | ||
| Q3 24 | $940.1M | — | ||
| Q2 24 | $965.2M | — | ||
| Q1 24 | $990.1M | — |
股东权益CNMDSTEX
| Q4 25 | $1.0B | — | ||
| Q3 25 | $1.0B | $-7.0M | ||
| Q2 25 | $1.0B | $-3.6M | ||
| Q1 25 | $977.6M | — | ||
| Q4 24 | $962.7M | $-1.5M | ||
| Q3 24 | $932.9M | $-405.0K | ||
| Q2 24 | $881.8M | $-6.0K | ||
| Q1 24 | $854.7M | $-4.3M |
总资产CNMDSTEX
| Q4 25 | $2.3B | — | ||
| Q3 25 | $2.3B | $130.5M | ||
| Q2 25 | $2.3B | $109.7M | ||
| Q1 25 | $2.3B | — | ||
| Q4 24 | $2.3B | $842.0K | ||
| Q3 24 | $2.3B | $1.4M | ||
| Q2 24 | $2.3B | $3.1M | ||
| Q1 24 | $2.3B | $1.6M |
负债/权益比CNMDSTEX
| Q4 25 | 0.81× | — | ||
| Q3 25 | 0.85× | — | ||
| Q2 25 | 0.88× | — | ||
| Q1 25 | 0.91× | — | ||
| Q4 24 | 0.94× | — | ||
| Q3 24 | 1.01× | — | ||
| Q2 24 | 1.09× | — | ||
| Q1 24 | 1.16× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $46.3M | $-5.0M |
| 自由现金流经营现金流 - 资本支出 | $41.2M | — |
| 自由现金流率自由现金流/营收 | 11.0% | — |
| 资本支出强度资本支出/营收 | 1.4% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $150.9M | — |
8季度趋势，按日历期对齐
经营现金流CNMDSTEX
| Q4 25 | $46.3M | — | ||
| Q3 25 | $53.7M | $-5.0M | ||
| Q2 25 | $29.1M | $-1.3M | ||
| Q1 25 | $41.5M | — | ||
| Q4 24 | $43.3M | $-474.0K | ||
| Q3 24 | $51.2M | $-1.5M | ||
| Q2 24 | $43.3M | $-1.5M | ||
| Q1 24 | $29.1M | $-1.3M |
自由现金流CNMDSTEX
| Q4 25 | $41.2M | — | ||
| Q3 25 | $48.5M | — | ||
| Q2 25 | $23.4M | — | ||
| Q1 25 | $37.8M | — | ||
| Q4 24 | $39.3M | — | ||
| Q3 24 | $47.8M | — | ||
| Q2 24 | $39.7M | — | ||
| Q1 24 | $27.1M | — |
自由现金流率CNMDSTEX
| Q4 25 | 11.0% | — | ||
| Q3 25 | 14.4% | — | ||
| Q2 25 | 6.8% | — | ||
| Q1 25 | 11.8% | — | ||
| Q4 24 | 11.4% | — | ||
| Q3 24 | 15.1% | — | ||
| Q2 24 | 12.0% | — | ||
| Q1 24 | 8.7% | — |
资本支出强度CNMDSTEX
| Q4 25 | 1.4% | — | ||
| Q3 25 | 1.5% | — | ||
| Q2 25 | 1.7% | — | ||
| Q1 25 | 1.2% | — | ||
| Q4 24 | 1.2% | — | ||
| Q3 24 | 1.1% | — | ||
| Q2 24 | 1.1% | — | ||
| Q1 24 | 0.7% | — |
现金转化率CNMDSTEX
| Q4 25 | — | — | ||
| Q3 25 | 18.78× | — | ||
| Q2 25 | 1.36× | — | ||
| Q1 25 | 6.88× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 1.05× | — | ||
| Q2 24 | 1.44× | — | ||
| Q1 24 | 1.48× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CNMD
| Transferred At Point In Time | $358.5M | 96% |
| Transferred Over Time | $14.7M | 4% |
STEX
暂无分部数据
